Table 1

Demographic and clinical characteristics of patients during anti-VEGF intravitreal injection treatment

Total eyes126
Patients, n (%)126
 Female97 (77)
 Male29 (33)
Age, mean±SD (years)79.5 (8.9)
Mean BCVA, mean±SD (ETDRS letters)63.7 (14.8)
Follow-up time, mean±SD (months)22.9 (13.5)
Previous anti-VEGF treatment, mean±SD, n10.4 (6.5)
IVI interval, mean±SD (months)2.35 (1.42)
CNV classification, n (%)
 Type 1107 (85)
 Type 221 (15)
  • BCVA, Best Corrected Visual Acuity; CNV, choroidal neovascularisation; IVI, intravitreal injection; VEGF, vascular endothelial growth factor.